Role of aldosterone in the remnant kidney model in the rat. - Wikidata - wikimedia - TriplyDB

Role of aldosterone in the remnant kidney model in the rat.

Role of aldosterone in the remnant kidney model in the rat.

http://www.wikidata.org/entity/Q37358980

about

Aldosterone antagonists for preventing the progression of chronic kidney disease Aldosterone antagonists for preventing the progression of chronic kidney disease Aldosterone antagonists for preventing the progression of chronic kidney disease Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease The ubiquitous mineralocorticoid receptor: clinical implications Mineralocorticoid receptor blockade in chronic kidney disease Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats Aldosterone as a determinant of cardiovascular and renal dysfunction Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.Comparison of spironolactone and trichlormethiazide as add-on therapy to renin-angiotensin blockade for reduction of albuminuria in diabetic patients Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells The impact of obstructive sleep apnea on chronic kidney disease.Metabolic acidosis and the progression of chronic kidney disease.Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ.Eplerenone--a novel selective aldosterone blocker.Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats Remission of renal disease: recounting the challenge, acquiring the goal Aldosterone and glomerular filtration--observations in the general population Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension.Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease Eplerenone in the treatment of chronic heart failure.Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis The effects of low calcium dialysate on arterial compliance and vasoactive substances in patients with hemodialysis.Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells.Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial?Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?Pharmacological management of renal fibrotic disease.CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches.

P2860

Q24194979-0C433A8D-3F98-4B7E-BE15-03052FC8A3A6 Q24239909-C607AFDC-1CC4-4D75-8BCE-ACA2823281BD Q24243615-72E061B0-6526-4F37-B1B6-F7CCCD014776 Q24294309-F9E41A4D-5970-4B51-BB42-05EC1B46E763 Q26752292-657556C1-5C61-4DAE-A741-C483C63821F9 Q26861721-FBCC94A3-3D51-40E9-BD17-347958EE865E Q26864370-AECDC69B-15D1-4D9E-A251-D453E78A56BD Q26996385-BA9E6403-D312-49F7-92FC-339565B15786 Q27333455-C1BFBD47-1C94-46FB-A94A-800AB9316F4E Q28344356-41B9EB14-CB19-409B-A520-B9C1096C61A7 Q30448786-642698FB-0097-414B-A077-75A3D6331063 Q33414957-011753FC-CC1E-4471-8C30-BCC060FAEACB Q33588914-9B9AAB69-F661-4A07-BEF1-EAA3F3A3424D Q33793187-F2AF4EF5-EBBF-44E8-B90B-3C5DB5F1D008 Q33871492-AD1A8A3F-B03B-4D02-AA2A-421AEAE23513 Q33891603-D85385C2-E56B-4EA1-BB53-8C792653F91F Q34018585-63C6899A-F5B2-439D-9EA9-F23273FDFA3F Q34075171-39903A06-A1BD-4CC8-8140-2C9A4D16AAC2 Q34139268-F9B24152-5C2A-48E3-B195-AE026A9041FD Q34288892-3DC8FC14-7355-44C1-A3ED-71DDA3BF4394 Q34414019-6BBB63BF-D0E8-4ED4-A044-F21CC5F6095D Q34595011-9E4240BE-3F72-4D99-B8CA-8B51EECE0BB7 Q34839549-4C761FAC-EFDF-4F8F-88E8-AFCCC14E642C Q34874363-7F306E86-D8F7-4300-84AC-354018053632 Q34947340-2598FAA9-83A0-491D-95F0-188EC247D1B8 Q35025420-D5A22C40-F320-45E7-A1EB-15BB45869616 Q35028657-6866291A-7837-442E-96AC-C99AF0B184AB Q35115799-7FA410F8-0F7B-40A1-B549-5FB63567BF95 Q35461760-6835B376-F537-4189-9833-0EE4235BF8C4 Q35543201-D28B7121-6E98-474F-9D90-0FEB31C194D4 Q35626544-63F07DA1-38D8-4637-B537-9B4398AE4F57 Q35777385-7B053AC0-23A2-4124-9C38-FE9977EFEF8D Q35868694-DE09E5CE-86DC-459F-9C3E-C5894FE1F985 Q35936844-ACE58D36-91DF-43F0-83CE-C3CBB410C8E9 Q36050919-3C07EE7E-088E-4942-8D4C-4F7935DA24BD Q36061883-84AAFF78-0A6D-41BC-88A3-17DD34C99D40 Q36124918-73A5312D-5373-42D8-B29A-595A0CBD645C Q36188436-53C56D2B-F0D1-4F68-B3B4-26A2877B5A54 Q36407348-F675209A-47F5-495A-8681-75496EE90B91 Q36426077-23F0BC5B-9ECB-4F1A-97F5-D5EB18A1207D

P2860

Role of aldosterone in the remnant kidney model in the rat.

http://www.wikidata.org/entity/Q37358980

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of aldosterone in the remnant kidney model in the rat.

@en

Role of aldosterone in the remnant kidney model in the rat.

@nl

type

label

Role of aldosterone in the remnant kidney model in the rat.

@en

Role of aldosterone in the remnant kidney model in the rat.

@nl

prefLabel

Role of aldosterone in the remnant kidney model in the rat.

@en

Role of aldosterone in the remnant kidney model in the rat.

@nl

P1433

Q37358980-7C15A01A-3EF7-4C6F-94DB-0D3DBB1B0C81

P1476

Q37358980-B1F77CF7-0917-467E-A497-C1248FE662BF

P2093

Q37358980-350C2D0D-CA3A-4018-8054-64E73EB06235

Q37358980-5A9716E5-4CDA-42B3-B418-1F2EB1061D48

Q37358980-785FE658-C264-429A-BE9B-650A0697AB9B

P2860

Q37358980-0DABAEC6-1F43-4F01-9B96-A2B89BF51A9D

Q37358980-1F2F9A14-91CA-4754-8E5B-9BB549464FCD

Q37358980-2E8E7270-EF71-443E-95D3-A6F55BB93BF6

Q37358980-3211A474-E7ED-489D-AD60-CD267AF80E4F

Q37358980-3BAF39E1-283D-46B5-84E9-3DF496ADF7D4

Q37358980-46BDDD59-E824-4043-8059-97AEA9447D85

Q37358980-59FA4014-BEAE-4574-BECF-02E305B05473

Q37358980-5AADA232-062E-4E64-BF98-C015ACF5687C

Q37358980-5EA82C2B-3668-41BD-958A-16DC7B77D086

Q37358980-64CA3F46-CBDA-4E30-8274-8F113571DEC7

P304

Q37358980-4A66C0C8-8D2F-4412-913B-C62EE50A2EEB

P31

Q37358980-219A3CE0-1ABB-4F1C-992B-7EC10FB21564

P356

Q37358980-20B25C28-A5D0-45F9-9D35-81A8E9054BDE

P407

Q37358980-604C2E25-113E-48F4-BB28-CAD5F3A55EFF

P433

Q37358980-2EAD7FB8-3D41-467A-A795-13E0D452204D

P478

Q37358980-1023ECB4-897D-41F7-9167-063E20AAB2F2

P577

Q37358980-AE27ADC3-D179-4D02-9A2B-820E3E670E98

P698

Q37358980-E8648DE7-4345-46DE-A7DC-15A14ED2589C

P932

Q37358980-11C0288A-6BFF-4286-BA1F-C7FBD7F4C6B8

P356

P1433

Journal of Clinical Investigation

P1476

Role of aldosterone in the remnant kidney model in the rat.

@en

P2093

E L Greene

http://www.w3.org/2001/XMLSchema#string

S Kren

http://www.w3.org/2001/XMLSchema#string

T H Hostetter

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.

N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

Long-term control of arterial blood pressure.

Mineralocorticoids, hypertension, and cardiac fibrosis.

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy.

The paradox of the renin-angiotensin system in chronic renal disease.

Hypertension-related renal injury: a major contributor to end-stage renal disease.

Sodium, extracellular fluid volume, and cardiac output changes in the genesis of mineralocorticoid hypertension in the intact dog.

P304

1063-1068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI118867

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8770880

http://www.w3.org/2001/XMLSchema#string

P932

507523

http://www.w3.org/2001/XMLSchema#string